Search

Your search keyword '"Ingo Frommann"' showing total 12 results
Start Over Author "Ingo Frommann" Publisher wiley
12 results on '"Ingo Frommann"'

1. F4‐08‐04: SUBJECTIVE COGNITIVE DECLINE, AS MEASURED WITH A STRUCTURED INTERVIEW, IS RELATED TO AMYLOID PATHOLOGY IN COGNITIVELY HEALTHY OLDER ADULTS

Author

Josef Priller, Peters Oliver, Michael T. Heneka, Annika Spottke, Anja Schneider, Christoph Laske, Emrah Düzel, Lisa Miebach, Frank Jessen, Jens Wiltfang, Sandra Roeske, Michael Ewers, Peter J. Nestor, Steffen Wolfsgruber, Michael Wagner, Stefan J. Teipel, Katharina Buerger, and Ingo Frommann

Subjects
Amyloid pathology, Epidemiology, business.industry, Health Policy, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Structured interview, Medicine, Neurology (clinical), Geriatrics and Gerontology, Cognitive decline, business, Clinical psychology
Published
2018

2. P2‐431: RELATIONSHIP BETWEEN LOCAL RESTING STATE ACTIVITY, β‐AMYLOID DEPOSITION AND MEMORY PERFORMANCE IN THE DZNE: LONGITUDINAL COGNITIVE IMPAIRMENT AND DEMENTIA STUDY (DELCODE)

Author

Klaus Fließbach, Martina Buchmann, Frank Jessen, Martin Dyrba, Jens Wiltfang, Michael J. Grothe, Barbara Kofler, Sandra Roeske, Frederic Brosseron, Alfredo Ramirez, Josef Priller, Christiana Franke, Christoph Laske, Ingo Frommann, Steffen Wolfsgruber, Michael Wagner, Ingo Kilimann, Manuela Thelen, Anja Schneider, Alexandra Polcher, Manuel Fuentes, Annika Spottke, Emrah Düzel, Xiaochen Hu, Michael T. Heneka, Judith Henf, Stefan J. Teipel, Katharina Buerger, Peters Oliver, Laura Dobisch, Felix Menne, Claudia Bartels, Daniel Bittner, Cihan Catak, Eike Jakob Spruth, and Coraline D. Metzger

Subjects
Resting state fMRI, Epidemiology, Chemistry, Health Policy, medicine.disease, Memory performance, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, β amyloid, medicine, Dementia, Neurology (clinical), Geriatrics and Gerontology, Cognitive impairment, Neuroscience, Deposition (chemistry)
Published
2018

3. P1-407: RELATIONSHIP BETWEEN GLOBAL CONNECTIVITY, AMYLOID AND TAU IN DIFFERENT STAGES DURING THE DEVELOPMENT OF ALZHEIMER'S DISEASE AS DEMONSTRATED IN THE DZNE DELCODE COHORT

Author

Josef Priller, Frank Jessen, Alexandra Polcher, Eike Jakob Spruth, Alfredo Ramirez, Laura Dobisch, Felix Menne, Steffen Wolfsgruber, Ingo Frommann, Anja Schneider, Klaus Fliessbach, Manuel Fuentes, Martina Buchmann, Manuela Thelen, Ingo Kilimann, Stefan J. Teipel, Michel J. Grothe, Jens Wiltfang, Martin Dyrba, Christoph Laske, Michael T. Heneka, Cihan Catak, Oliver Peters, Barbara Kofler, Frederic Brosseron, Katharina Bürger, Claudia Bartels, Christiana Franke, Daniel Bittner, Annika Spottke, Emrah Düzel, Xiaochen Hu, Sandra Roeske, Michael Wagner, and Coraline D. Metzger

Subjects
Oncology, medicine.medical_specialty, Amyloid, Epidemiology, business.industry, Health Policy, Disease, 03 medical and health sciences, Psychiatry and Mental health, Cellular and Molecular Neuroscience, 0302 clinical medicine, Developmental Neuroscience, 030225 pediatrics, Internal medicine, Cohort, medicine, Neurology (clinical), Geriatrics and Gerontology, business, 030217 neurology & neurosurgery
Published
2019

4. [P1–320]: INTERPRETATIVE PHENOMENOLOGICAL ANALYSIS OF COGNITIVE COMPLAINTS REVEALS COMMONALITIES AND DIFFERENCES BETWEEN MEMORY‐CLINIC PATIENTS, DEPRESSIVE PATIENTS, AND HEALTHY ELDERLY

Author

Frank Jessen, Steffen Wolfsgruber, Rachel F. Buckley, Klaus Fließbach, Lisa Miebach, Ingo Frommann, and Michael Wagner

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Interpretative phenomenological analysis, Epidemiology, Health Policy, Memory clinic, Cognition, Neurology (clinical), Healthy elderly, Geriatrics and Gerontology, Psychology, Clinical psychology
Published
2017

5. P1‐217: Cognitive Complaint Profiles in Memory Clinic and Depressive Patients

Author

Lisa Miebach, Ingo Frommann, Michael Wagner, Steffen Wolfsgruber, and Rachel F. Buckley

Subjects
medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Memory clinic, Cognition, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, medicine, Complaint, Neurology (clinical), Geriatrics and Gerontology, Psychiatry, business, Clinical psychology
Published
2016

6. P50 sensory gating and smoking in the general population

Author

Francesco Musso, Georg Winterer, Thomas F. Wienker, Norbert Thuerauf, Gerhard Gründer, Ingo Frommann, Arian Mobascher, Jürgen Gallinat, Melanie Schmitz, Katja N. Spreckelmeyer, Norbert Dahmen, Jürgen Brinkmeyer, Daniela A. Holler, Falk Kiefer, Amalia Diaz-Lacava, Marion Clepce, Michael Wagner, and Walter de Millas

Subjects
Pharmacology, Fagerstrom Test for Nicotine Dependence, education.field_of_study, medicine.medical_specialty, Sensory gating, Population, Medicine (miscellaneous), Gating, Audiology, medicine.disease, Brain mapping, Functional imaging, Psychiatry and Mental health, medicine.anatomical_structure, Schizophrenia, Endophenotype, medicine, education, Psychology, Neuroscience
Abstract

P50 gating is a major functional biomarker in research on schizophrenia and other psychiatric conditions with high smoking prevalence. It is used as endophenotype for studying nicotinic systems genetics and as surrogate endpoint measure for drug development of nicotinic agonists. Surprisingly, little is known about P50 gating in the general population and the relationship to smoking-related characteristics. In this multicenter study at six academic institutions throughout Germany, n = 907 never-smokers (NS

Published
2011

7. P2‐192: Face‐name associative recognition is impaired in patients with subjective cognitive decline

Author

Frank Jessen, Alexander Koppara, Ingo Frommann, Alexandra Polcher, and Michael Wagner

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Face (sociological concept), In patient, Neurology (clinical), Geriatrics and Gerontology, Cognitive decline, Psychology, Associative property, Cognitive psychology
Published
2015

8. P4‐057: Slowly progressing logopenic aphasia in a patient with a TREM2 (p.T96K) mutation

Author

Klaus Fliessbach, Alexander Drzezga, Ingo Frommann, Frank Jessen, and Alfredo Ramirez

Subjects
Oncology, medicine.medical_specialty, Epidemiology, business.industry, TREM2, Health Policy, Logopenic aphasia, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Internal medicine, Mutation (genetic algorithm), medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2015

9. P2‐240: IMPAIRED VISUAL FEATURE BINDING IN PATIENTS AT RISK FOR ALZHEIMER'S DISEASE: EVIDENCE FROM PATIENTS WITH SUBJECTIVE COGNITIVE DECLINE (SCD) AND FROM PATIENTS WITH MCI

Author

Michael Wagner, Parra A. Mario, Alexander Koppara, Ingo Frommann, Frank Jessen, Alexandra Polcher, and Thomas Klockgether

Subjects
medicine.medical_specialty, Epidemiology, Health Policy, Disease, language.human_language, German, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Cognitive epidemiology, Developmental Neuroscience, language, medicine, In patient, Neurology (clinical), Cognitive ageing, Geriatrics and Gerontology, Cognitive decline, Psychiatry, Psychology
Abstract

Alexander Koppara, Michael Wagner, Alexandra Polcher, Ingo Frommann, Thomas Klockgether, Frank Jessen, Parra A. Mario, 1 Department of Psychiatry and Psychotherapy, Rheinische-Friedrich-Wilhelms University Bonn, Bonn, Germany; 2 German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; DZNE, German Center for Neurodegenerative Diseases, Bonn, Germany; 4 Department of Psychiatry, Bonn, Germany; 5 DZNE, Bonn, Germany; Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, United Kingdom. Contact e-mail: Michael.Wagner@uni-bonn.de

Published
2014

10. P1‐018: HIPPOCAMPAL GREY MATTER ATROPHY IS ASSOCIATED WITH THE FREE AND CUED SELECTIVE REMINDING TEST

Author

Eva Burkei, Dix Meiberth, Ingo Frommann, Frank Jessen, Wolfgang Block, Lukas Scheef, Xiaochen Hu, Michael T. Heneka, Michael Wagner, Hans H. Schild, and Sandra Röske

Subjects
Cued speech, Grey matter atrophy, Epidemiology, Health Policy, Hippocampal formation, Test (assessment), Developmental psychology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Neurology (clinical), Geriatrics and Gerontology, Psychology, Neuroscience
Published
2014

12. P4‐240: Homocysteine metabolism and CSF markers for Alzheimer's disease

Author

Frank Jessen, Michael Linnebank, Gabriela Cvertanovska, Piotr Lewczuk, Ingo Frommann, Johannes Kornhuber, Wolfgang Maier, Julius Popp, Yvo M. Smulders, and Heike Kölsch

Subjects
Apolipoprotein E, medicine.medical_specialty, Creatinine, Homocysteine, Epidemiology, business.industry, Health Policy, Disease, Pathophysiology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, chemistry.chemical_compound, Endocrinology, Cerebrospinal fluid, Developmental Neuroscience, chemistry, Internal medicine, mental disorders, medicine, Neurology (clinical), Geriatrics and Gerontology, Allele, Risk factor, business
Abstract

Disturbed homocysteine metabolism is a risk factor for Alzheimer's disease (AD) and may contribute to the disease pathophysiology by increasing both amyloid-beta (Abeta) production and phosphorylated tau (P-tau) accumulation. Here, we evaluated the relationship between the cerebrospinal fluid (CSF) concentrations of homocysteine (Hcys), S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), and 5-methyltetrahydrofolate (5-MTHF), and the markers for AD pathology, amyloid-beta (Abeta) _{1-42} and P-tau181, in 98 cognitively healthy subjects aged 16-81 years and 54 AD patients. In multivariate regression tests including age, gender, creatinine, and presence of the apolipoprotein E epsilon4 allele, P-tau181 was associated with SAH (beta = 0.490; p _{1-42} were not associated with the CSF concentrations of Hcys, SAM, SAH, or 5-MTHF neither in the AD nor in the control group. The results suggest that alteration of the homocysteine metabolism is related to increased accumulation of phosphorylated tau and may contribute to the neurofibrillary pathology in normal aging and in AD.

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results